What is Cystic Fibrosis?

What is the Cause of the Defect and its Systemic Impact?

The cause is a mutation in the CFTR gene (Cystic Fibrosis Transmembrane Conductance Regulator). This defective gene controls the movement of salt and water in and out of cells, leading to thick, sticky secretions instead of thin, slippery ones. This buildup severely clogs ducts, airways, and passageways throughout the body, causing permanent organ damage. The severity of the disease depends on the specific mutation, dictating the overall life expectancy and quality of life.

What Symptoms are Associated with Secretion Buildup and Chronic Damage?

Symptoms are associated with organ blockage. In the lungs, thick mucus causes chronic, severe infections and breathing difficulty. This constant cycle of infection and inflammation leads to irreversible lung damage (bronchiectasis). In the digestive tract, clogged pancreatic ducts prevent enzymes from reaching the small intestine, leading to malabsorption and severe weight loss. Patients also lose excessive amounts of salt in their sweat, which can cause dehydration and electrolyte imbalance.

Diagnostic Procedures and Newborn Screening

Diagnosis is often made shortly after birth through newborn screening (heel-prick test). Due to the high salt content in sweat, a definitive diagnosis is confirmed using a sweat test, which measures the concentration of chloride. Imaging and genetic testing are also used to identify the specific gene mutation and track organ damage.

How Does This Condition Impact Vision or Eye Health?

Cystic Fibrosis impacts eye health indirectly due to chronic severe illness and necessary medications. Patients often experience severe dry eye due to poor tear film quality. Additionally, some high-dose antibiotics used to fight severe lung infections can rarely cause side effects that affect visual function.

Modern Management Strategies

Modern management strategies have drastically improved the outlook. Treatment involves medications that help thin the mucus, antibiotics to fight chronic infections, airway clearance techniques, and CFTR modulators, which target the underlying genetic defect to improve channel function.